Niraparib in High-grade Endometrial Cancer Trial
NCT05289648
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Unable to obtain funding
Conditions
Endometrial Cancer
Serous Adenocarcinoma
Uterine Neoplasm
Interventions
DRUG:
Niraparib oral capsule
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital